Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ramanathan

Showing results (291-300 of 302) with videos related to

Pageof 31
Sort By:
Plos One|October 17, 2012
Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencingWinnie S Liang, David W Craig, John Carpten, et al.
JCI Insight|February 23, 2018
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumorsStergios J Moschos, Ryan J Sullivan, Wen-Jen Hwu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2017
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced CholangiocarcinomaMilind Javle, Maeve Lowery, Rachna T Shroff, et al.
Physical Review Letters|January 7, 2021
Results on Low-Mass Weakly Interacting Massive Particles from an 11 kg d Target Exposure of DAMIC at SNOLABA Aguilar-Arevalo, D Amidei, D Baxter, et al.
Nature|March 8, 2019
Hepatocytes direct the formation of a pro-metastatic niche in the liverJae W Lee, Meredith L Stone, Paige M Porrett, et al.
Physical Review Letters|November 26, 2019
Constraints on Light Dark Matter Particles Interacting with Electrons from DAMIC at SNOLABA Aguilar-Arevalo, D Amidei, D Baxter, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2015
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapiesVincent J Picozzi, Ramesh K Ramanathan, Maeve A Lowery, et al.
Physical Review Letters|April 22, 2017
First Direct-Detection Constraints on eV-Scale Hidden-Photon Dark Matter with DAMIC at SNOLABA Aguilar-Arevalo, D Amidei, X Bertou, et al.
Scientific Reports|December 23, 2016
Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced CancersMitesh J Borad, Jan B Egan, Rachel M Condjella, et al.
Physical Review Letters|May 12, 2023
First Constraints from DAMIC-M on Sub-GeV Dark-Matter Particles Interacting with ElectronsI Arnquist, N Avalos, D Baxter, et al.
Pageof 31

Showing results (291-300 of 302) with videos related to

Sort By:
Pageof 31
Plos One|October 17, 2012
Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencingWinnie S Liang, David W Craig, John Carpten, et al.
JCI Insight|February 23, 2018
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumorsStergios J Moschos, Ryan J Sullivan, Wen-Jen Hwu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2017
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced CholangiocarcinomaMilind Javle, Maeve Lowery, Rachna T Shroff, et al.
Physical Review Letters|January 7, 2021
Results on Low-Mass Weakly Interacting Massive Particles from an 11 kg d Target Exposure of DAMIC at SNOLABA Aguilar-Arevalo, D Amidei, D Baxter, et al.
Nature|March 8, 2019
Hepatocytes direct the formation of a pro-metastatic niche in the liverJae W Lee, Meredith L Stone, Paige M Porrett, et al.
Physical Review Letters|November 26, 2019
Constraints on Light Dark Matter Particles Interacting with Electrons from DAMIC at SNOLABA Aguilar-Arevalo, D Amidei, D Baxter, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2015
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapiesVincent J Picozzi, Ramesh K Ramanathan, Maeve A Lowery, et al.
Physical Review Letters|April 22, 2017
First Direct-Detection Constraints on eV-Scale Hidden-Photon Dark Matter with DAMIC at SNOLABA Aguilar-Arevalo, D Amidei, X Bertou, et al.
Scientific Reports|December 23, 2016
Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced CancersMitesh J Borad, Jan B Egan, Rachel M Condjella, et al.
Physical Review Letters|May 12, 2023
First Constraints from DAMIC-M on Sub-GeV Dark-Matter Particles Interacting with ElectronsI Arnquist, N Avalos, D Baxter, et al.
Pageof 31